Log in or Sign up for Free to view tailored content for your specialty!
HIV/AIDS News
Six stories for HIV Vaccine Awareness Day
Globally, more than 37 million people are living with HIV, nearly two-thirds of them in Africa.
Study demonstrates African women’s long-term use and adherence to ART
A study demonstrated that African women with HIV used ART for years and maintained high adherence, benefiting both themselves and their children.
Log in or Sign up for Free to view tailored content for your specialty!
HIV cure research: Trying to eliminate a virus that ‘hides out’
After more than 40 years, scientists have yet to find a cure for HIV, a complex virus that can be suppressed with potent medications to undetectable levels in the body but not eliminated.
FDA approves long-acting injectable HIV regimen for adolescents
The FDA on Tuesday approved the first long-acting HIV treatment regimen for adolescents.
Study suggests young women prefer vaginal ring over oral PrEP for HIV prevention
Adolescent girls and young women preferred the dapivirine ring over oral PrEP for HIV prevention by a two to one margin in a study conducted in three African countries, researchers reported Tuesday.
Study shows bNAbs may be viable treatment for children with HIV
Broadly neutralizing monoclonal antibodies, or bNAbs, may be a viable treatment option for young children with HIV, according to study findings presented at the Conference on Retroviruses and Opportunistic Infections.
Study findings demonstrate risk to infants from maternal COVID-19, HIV
Maternal COVID-19 was associated with an increased risk for adverse birth outcomes among infants born to mothers in Botswana, including a two-fold risk for stillbirth, researchers found.
Nearly 9% of people prescribed PrEP abandoned their prescriptions in 2019
The first study to assess PrEP abandonment at retail pharmacies in the United States found that almost 9% of patients aged 16 years or older failed to pick up their prescriptions in 2019.
AAP recommends universal HIV screening starting at age 15 years
The AAP updated its guidance to recommend that all adolescents aged 15 years or older be screened for HIV at least once in a health care setting and that youth at an increased risk be screened at least once annually after that.
FDA approves first long-acting injectable for HIV prevention
The FDA on Monday approved ViiV Healthcare’s cabotegravir as the first long-acting injectable for HIV PrEP.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read